A Once-in-a-Decade Buying Opportunity Emerges! Three Stocks Not to Be Missed

Life Science

Why Alnylam Soared 6%: One Analyst Says the Biotech’s Growth Story Is Just Getting Started

Life Science

CRISPR Therapeutics Soars as Partner Vertex Drops Optimistic 2026 Sales Guidance

Life Science

From AbbVie to CRISPR: 6 Must-Watch Healthcare Stocks for 2026

Life Science

AI Empowers New Drug Development at the Right Time: These Two Biotech Stocks Are Not to Be Missed

Life Science

Four ETFs May Usher in Explosive Growth

Life Science

Is Pfizer’s Turnaround Story Worth a Closer Look?

Life Science

Is Johnson & Johnson Still a Worthy Investment in 2026?

Life Science

Iradimed Stock Surges as Record Quarterly Revenue Streak Hits 18

Life Science

Revenue Highly Dependent on the GLP-1 Track: How Does Lilly Balance Growth and Risk?

Life Science

Hims & Hers Stock Plunges 25% After Abandoning Copycat Wegovy Pill

Life Science

Novo Nordisk Crashes 68%: Is It Time to Buy the Dip?

Life Science

Biogen’s Financial Report and Outlook Exceed Expectations, Stock Soars Nearly 9% on Friday 

Life Science

Amazon Begins Selling Oral Weight-Loss Drug Wegovy, Intensifying Competition in the GLP-1 Retail Market

Life Science

Why Did This Pharma Stock Defy the Market Downturn Today?

Life Science